ENST00000507735.6:c.199C>T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The ENST00000507735.6(PALLD):​c.199C>T​(p.Pro67Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000774 in 1,292,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P67R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.7e-7 ( 0 hom. )

Consequence

PALLD
ENST00000507735.6 missense

Scores

4
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.49

Publications

0 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000507735.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.35443157).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000507735.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
NM_001166108.2
MANE Select
c.1965-12832C>T
intron
N/ANP_001159580.1Q8WX93-9
PALLD
NM_001166110.2
c.199C>Tp.Pro67Ser
missense
Exon 2 of 12NP_001159582.1Q8WX93-4
PALLD
NM_016081.4
c.1965-12832C>T
intron
N/ANP_057165.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
ENST00000507735.6
TSL:1
c.199C>Tp.Pro67Ser
missense
Exon 2 of 12ENSP00000424016.1Q8WX93-4
PALLD
ENST00000505667.6
TSL:1 MANE Select
c.1965-12832C>T
intron
N/AENSP00000425556.1Q8WX93-9
PALLD
ENST00000261509.10
TSL:1
c.1965-12832C>T
intron
N/AENSP00000261509.6Q8WX93-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.74e-7
AC:
1
AN:
1292088
Hom.:
0
Cov.:
31
AF XY:
0.00000157
AC XY:
1
AN XY:
635122
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25996
American (AMR)
AF:
0.0000468
AC:
1
AN:
21378
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20520
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28708
South Asian (SAS)
AF:
0.00
AC:
0
AN:
65966
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32246
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4278
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1039398
Other (OTH)
AF:
0.00
AC:
0
AN:
53598
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.079
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
8.5
DANN
Uncertain
0.99
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.15
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.79
T
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.35
T
MetaSVM
Benign
-0.86
T
PhyloP100
3.5
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.17
Sift
Benign
0.064
T
Sift4G
Uncertain
0.041
D
Mutation Taster
=43/57
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1060502975;
hg19: chr4-169799241;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.